Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

NKTR-358 demonstrates safety, tolerability and promotes regulatory T-cell responses

June 14, 2019

Phase II study of Lyme disease vaccine candidate VLA-15 enters main study phase

June 13, 2019

Bristol-Myers Squibb patents TYK2 inhibitors

June 12, 2019

Clinical data show potential for improved renal transplant outcomes with CFZ-533

June 12, 2019

Tree SLIT-tablet against allergic rhinitis approved in Europe

June 11, 2019

Vaccitech initiates phase IIb study of MVA-NP+M1 universal flu vaccine in Belgium

June 6, 2019

CEPI provides funding to support Themis' development of chikungunya vaccine MK-CHIK

June 4, 2019

Cracking influenza's egg code

June 4, 2019

Talaris presents quality-of-life data on FCR-001

June 3, 2019

CSIR synthesizes new TLR9 antagonists

May 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...